Su Guo1. 1. Department of Biopharmaceutical Sciences, Programs in Biological Sciences and Human Genetics, Institute for Regenerative Medicine, University of California San Francisco, CA 94143-2811.
Abstract
BACKGROUND: Zebrafish is becoming an increasingly attractive model organism for understanding biology and developing therapeutics, because as a vertebrate, it shares considerable similarity with mammals in both genetic compositions and tissue/organ structures, and yet remains accessible to high throughput phenotype-based genetic and small molecule compound screening. OBJECTIVE/ METHOD: The focus of this review is on the nervous system, which is arguably the most complex organ and known to be afflicted by more than six hundred disorders in humans. I discuss the past, present, and future of using zebrafish to assess the impact of small molecule drugs on neural development and function, in light of understanding and treating neurodevelopmental disorders such as autism, neurodegenerative disorders including Alzheimer's, Parkinson's, and Hungtington's disease, and neural system dysfunctions such as anxiety/depression and addiction. CONCLUSION: These studies hold promise to reveal fundamental mechanisms governing nervous system development and function, and to facilitate small molecule drug discovery for the many types of neurological disorders.
BACKGROUND:Zebrafish is becoming an increasingly attractive model organism for understanding biology and developing therapeutics, because as a vertebrate, it shares considerable similarity with mammals in both genetic compositions and tissue/organ structures, and yet remains accessible to high throughput phenotype-based genetic and small molecule compound screening. OBJECTIVE/ METHOD: The focus of this review is on the nervous system, which is arguably the most complex organ and known to be afflicted by more than six hundred disorders in humans. I discuss the past, present, and future of using zebrafish to assess the impact of small molecule drugs on neural development and function, in light of understanding and treating neurodevelopmental disorders such as autism, neurodegenerative disorders including Alzheimer's, Parkinson's, and Hungtington's disease, and neural system dysfunctions such as anxiety/depression and addiction. CONCLUSION: These studies hold promise to reveal fundamental mechanisms governing nervous system development and function, and to facilitate small molecule drug discovery for the many types of neurological disorders.
Authors: Hyung-Goo Kim; Shotaro Kishikawa; Anne W Higgins; Ihn-Sik Seong; Diana J Donovan; Yiping Shen; Eric Lally; Lauren A Weiss; Juliane Najm; Kerstin Kutsche; Maria Descartes; Lynn Holt; Stephen Braddock; Robin Troxell; Lee Kaplan; Fred Volkmar; Ami Klin; Katherine Tsatsanis; David J Harris; Ilse Noens; David L Pauls; Mark J Daly; Marcy E MacDonald; Cynthia C Morton; Bradley J Quade; James F Gusella Journal: Am J Hum Genet Date: 2008-01 Impact factor: 11.025
Authors: Jonathan Cachat; Adam Stewart; Leah Grossman; Siddharth Gaikwad; Ferdous Kadri; Kyung Min Chung; Nadine Wu; Keith Wong; Sudipta Roy; Christopher Suciu; Jason Goodspeed; Marco Elegante; Brett Bartels; Salem Elkhayat; David Tien; Julia Tan; Ashley Denmark; Thomas Gilder; Evan Kyzar; John Dileo; Kevin Frank; Katie Chang; Eli Utterback; Peter Hart; Allan V Kalueff Journal: Nat Protoc Date: 2010-10-14 Impact factor: 13.491
Authors: Deniz Baycin-Hizal; Yuan Tian; Ilhan Akan; Elena Jacobson; Dean Clark; Alexander Wu; Russell Jampol; Karen Palter; Michael Betenbaugh; Hui Zhang Journal: Anal Chem Date: 2011-06-08 Impact factor: 6.986